BridgeBio Pharma, Inc. (BBIO): SCHEDULE 13D/A filed May 14, 2025

Form type

SCHEDULE 13D/A

Filing date

May 14, 2025

Accession number

0001140361-25-019024

Filer

BridgeBio Pharma, Inc. (CIK 1743881)